CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
162 hedge funds and large institutions have $3.22B invested in China Biologic Products Holdings, Inc. in 2016 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 60 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
24% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $24.1M
Holders
162
Holding in Top 10
8
Calls
$18.3M
Puts
$24.1M
Top Buyers
| 1 | +$54.2M | |
| 2 | +$37.1M | |
| 3 | +$27.7M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$24.1M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$19.9M |
Top Sellers
| 1 | -$163B | |
| 2 | -$63.3M | |
| 3 | -$33.3M | |
| 4 |
SFM
Soros Fund Management
New York
|
-$25.2M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
-$14.8M |